Home › Rectal Cancer › Virginia › Arlington
Rectal Cancer clinical trials in Arlington, VA
5 studies for Rectal Cancer are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
RecruitingPhase 3
- Virginia Cancer Specialists, PC ( Site 0069), Fairfax · 11 mi away
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi away
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RecruitingPhase 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · 11 mi away
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Recruiting
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi away
- Kaiser Permanente-Burke Medical Center, Burke · 11 mi away
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RecruitingPhase 1
- NEXT Virginia, Fairfax · 11 mi away
Rectal Cancer trials in other cities
- New York City, NY17 studies
- Boston, MA12 studies
- Houston, TX11 studies
- St. Louis, MO11 studies
- Los Angeles, CA10 studies
- Columbus, OH10 studies
- Tampa, FL9 studies
- Seattle, WA9 studies
- Nashville, TN9 studies
- Rochester, MN8 studies
- Chicago, IL8 studies
- Aurora, CO8 studies
Other studies in Arlington
- Non-Small Cell Lung Cancer104 studies
- Metastatic Cancer53 studies
- Colorectal Cancer52 studies
- Cancer (all types)48 studies
- Breast Cancer46 studies
- Ovarian Cancer46 studies
- Lung Cancer41 studies
- Endometrial Cancer39 studies
- Pancreatic Cancer33 studies
- Head and Neck Squamous Cell Carcinoma26 studies
- Small Cell Lung Cancer23 studies
- Triple-Negative Breast Cancer20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.